CDx Labs., Inc. v. Zila, Inc.

2018 NY Slip Op 4693
CourtAppellate Division of the Supreme Court of the State of New York
DecidedJune 27, 2018
Docket2016-03519
StatusPublished

This text of 2018 NY Slip Op 4693 (CDx Labs., Inc. v. Zila, Inc.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CDx Labs., Inc. v. Zila, Inc., 2018 NY Slip Op 4693 (N.Y. Ct. App. 2018).

Opinion

CDx Labs., Inc. v Zila, Inc. (2018 NY Slip Op 04693)
CDx Labs., Inc. v Zila, Inc.
2018 NY Slip Op 04693
Decided on June 27, 2018
Appellate Division, Second Department
Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.
This opinion is uncorrected and subject to revision before publication in the Official Reports.


Decided on June 27, 2018 SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Second Judicial Department
JOHN M. LEVENTHAL, J.P.
JEFFREY A. COHEN
ROBERT J. MILLER
JOSEPH J. MALTESE, JJ.

2016-03519
(Index No. 30655/13)

[*1]CDx Laboratories, Inc., et al., appellants,

v

Zila, Inc., defendant, Henry Schein, Inc., respondent.


Ellenoff Grossman & Schole, LLP, New York, NY (James K. Landau and Frank Spano of counsel), for appellants.

Proskauer Rose, LLP, New York, NY (Jordan B. Leader, Alyse F. Stach, and Kevin Perra of counsel), for respondent.



DECISION & ORDER

In an action to recover damages for misappropriation of trade secrets, unfair competition, and tortious interference with business relations, the plaintiffs appeal from an order of the Supreme Court, Rockland County (Victor J. Alfieri, Jr., J.), dated March 7, 2016. The order denied the plaintiffs' motion for leave to amend the complaint to assert a cause of action to recover damages for breach of contract against the defendant Henry Schein, Inc.

ORDERED that the order is affirmed, with costs.

The plaintiffs, CDx Laboratories, Inc. (hereinafter CDx), and Oral Cancer Prevention International, Inc., commenced this action on February 1, 2013, alleging causes of action to recover damages for misappropriation of trade secrets, unfair competition, and tortious interference with business relations. On May 13, 2015, the plaintiffs moved for leave to amend the complaint to assert a cause of action to recover damages for breach of contract against the defendant Henry Schein, Inc. (hereinafter Schein). By order dated March 7, 2016, the Supreme Court denied the motion. The plaintiffs appeal.

"In the absence of prejudice or surprise to the opposing party, leave to amend a pleading should be freely granted unless the proposed amendment is palpably insufficient or patently devoid of merit" (Mannino v Wells Fargo Home Mtge. Inc., 155 AD3d 860, 862; see CPLR 3025[b]; Assevero v Hamilton & Church Props., LLC, 154 AD3d 728; Lucido v Mancuso, 49 AD3d 220). " A determination whether to grant such leave is within the Supreme Court's broad discretion, and [*2]the exercise of that discretion will not be lightly disturbed'" (Finkelstein v Lincoln Natl. Corp., 107 AD3d 759, 761, quoting Gitlin v Chirinkin, 60 AD3d 901, 902; see Cullen v Torsiello, 156 AD3d 680).

A cause of action alleging breach of contract is governed by a six-year statute of limitations (see CPLR 213[2]) and accrues at the time of the alleged breach (see Hahn Automotive Warehouse, Inc. v American Zurich Ins. Co., 18 NY3d 765). Here, even assuming that the relation-back doctrine applies and that the plaintiffs' proposed breach of contract cause of action is deemed interposed at the time that the original complaint was filed (see CPLR 203[1][f]; O'Halloran v Metropolitan Transp. Auth., 154 AD3d 83, 86; Cady v Springbrook NY, Inc., 145 AD3d 846, 846-847), the statute of limitations for asserting that cause of action has expired. The proposed amended complaint alleges only that Schein breached a certain agreement with CDx "regularly," "[b]eginning in or around 2002." No allegations are made, and the plaintiffs' evidence otherwise fails to establish, that Schein breached the agreement within the six years immediately preceding the filing of the original complaint; that is, after February 1, 2007 (see CPLR 213[2]). Accordingly, the plaintiffs' motion for leave to amend the complaint was properly denied (see Cady v Springbrook NY, Inc., 145 AD3d 846; Carroll v Motola, 109 AD3d 629, 630; Fisher v Giuca, 69 AD3d 671; Clark v Foley, 240 AD2d 458; cf. Katz v Beil, 142 AD3d 957).

LEVENTHAL, J.P., COHEN, MILLER and MALTESE, JJ., concur.

ENTER:

Aprilanne Agostino

Clerk of the Court



Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hahn Automotive Warehouse, Inc. v. American Zurich Insurance
967 N.E.2d 1187 (New York Court of Appeals, 2012)
Katz v. Beil
142 A.D.3d 957 (Appellate Division of the Supreme Court of New York, 2016)
Cady v. Springbrook NY, Inc.
2016 NY Slip Op 8495 (Appellate Division of the Supreme Court of New York, 2016)
O'Halloran v. Metropolitan Transportation Authority
2017 NY Slip Op 6237 (Appellate Division of the Supreme Court of New York, 2017)
Assevero v. Hamilton & Church Properties, LLC
2017 NY Slip Op 7103 (Appellate Division of the Supreme Court of New York, 2017)
Mannino v. Wells Fargo Home Mortgage, Inc.
2017 NY Slip Op 7989 (Appellate Division of the Supreme Court of New York, 2017)
Cullen v. Torsiello
2017 NY Slip Op 8654 (Appellate Division of the Supreme Court of New York, 2017)
Lucido v. Mancuso
49 A.D.3d 220 (Appellate Division of the Supreme Court of New York, 2008)
Gitlin v. Chirinkin
60 A.D.3d 901 (Appellate Division of the Supreme Court of New York, 2009)
Fisher v. Giuca
69 A.D.3d 671 (Appellate Division of the Supreme Court of New York, 2010)
Carroll v. Motola
109 A.D.3d 629 (Appellate Division of the Supreme Court of New York, 2013)
Clark v. Foley
240 A.D.2d 458 (Appellate Division of the Supreme Court of New York, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
2018 NY Slip Op 4693, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cdx-labs-inc-v-zila-inc-nyappdiv-2018.